DRI Sezed 107 Litres Of Liquid Mephedrone From Apex Medichem

Ahmedabad: After the mega drug bust carried out jointly by the Directorate of Revenue Intelligence (DRI) Pune and Ahmedabad Crime Branch on October 21 at a factory in Maharashtra’s Aurangabad, another factory came under crackdown in the city on Saturday.

Banned drugs worth about Rs 160 crore have been recovered in the latest case, officials said.

The owner of the factory and the warehouse manager have been arrested under the provisions of the Narcotic Drugs and Psychotropic Substances (NDPS) Act.

“The search of the factory premises of a company named Apex Medichem Pvt. Ltd. resulted in the recovery of about 107 litres of liquid Mephedrone. The Illicit market value of these narcotics drugs and psychotropic substances has been reported to be approximately Rs160 crore, ” stated an official release.

 

Related Posts

  • Pharma
  • June 17, 2025
  • 66 views
Biocon launches Rs 4,500-crore QIP; to issue 11.6% of equity base

Bengaluru-based biopharmaceutical firm Biocon on Monday launched a qualified institutions placement (QIP) to raise Rs 4,500 crore. As part of the offering, the firm will issue up to 139 million…

  • Pharma
  • June 17, 2025
  • 78 views
Zydus Healthcare appoints Swati Dalal MD

Zydus Lifesciences Ltd on Monday announced the appointment of Swati Dalal as an additional director and Managing Director of its wholly-owned arm Zydus Healthcare Ltd. The board of Zydus Healthcare…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Biocon launches Rs 4,500-crore QIP; to issue 11.6% of equity base

Biocon launches Rs 4,500-crore QIP; to issue 11.6% of equity base

Zydus Healthcare appoints Swati Dalal MD

Zydus Healthcare appoints Swati Dalal MD

Natco Pharma appoints Yarramshetty Krishna Rao as Senior Vice President – Operations at Mekaguda

Natco Pharma appoints Yarramshetty Krishna Rao as Senior Vice President – Operations at Mekaguda

Natco API plant gets one observation from FDA

Natco API plant gets one observation from FDA